Biotechnology News

July 10, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends examines current trends in the management of RA from the perspective of rheumatologists with a focus on analyzing their attitudes, perceptions and self-reported prescribing behavior.

July 10, 2012

LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc. today announced a major expansion of the company’s U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems.

July 10, 2012

ZURICH & NEW YORK--(BUSINESS WIRE)--EBD Group and Inova Software form strategic collaboration to improve partnering productivity and business outcomes for the life science industry

July 10, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the pricing of its previously announced...

July 10, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today announced that Chief Executive Officer Timothy Ruane will speak at the 7th Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 10:30 am Eastern...

July 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus initiatied a Phase 1 multiple ascending dose (MAD) clinical study with Z944, its novel, oral, T-type calcium channel blocker.

July 10, 2012

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of hybrid and genetically modified crop seeds in China, today provided update on its Genetically Modified (“GM”) corn seed...

July 10, 2012

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--CRI Lifetree opened a new state-of-the-art, early stage research facility in Marlton, N.J.

July 10, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on...

July 10, 2012

CONCORD, Ohio--(BUSINESS WIRE)--Ricerca Biosciences announces Dr. G. Lynn Miesel as the new technical director.

July 10, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma announced that the United States Patent and Trademark Office has allowed three new patents covering the Company’s lead product candidate, APF530.

July 10, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Ablexis, LLC, a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative platform for discovery of the next generation of breakthrough antibody drugs, today announced another non-exclusive...

July 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Galenea & Eisai collaboration aims to understand synaptic changes in neurodegeneration, discover new class of synaptic modulator drugs

July 10, 2012

NEW YORK & PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

July 10, 2012

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that J-Plasma™ is performing well in both laparoscopic and open surgeries. In...

July 10, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis to present at upcoming conferences

July 10, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular Therapeutics” or the Company”) (NYSE MKT: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance...

July 10, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences Announces Resubmission of Raxibacumab BLA to FDA; FDA acknowledges receipt and sets PDUFA action date of December 15, 2012

July 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Charles Butler, the company’s vice president of investor relations and corporate communications, will present at the JMP Securities 7th Annual...

July 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, InVivo Therapeutics Chief Executive...

July 10, 2012

OXFORD, England--(BUSINESS WIRE)--AbD Serotec announces the launch of its bovine and ovine Dendritic Cell Growth Kits and a complementary panel of antibodies for dendritic cell phenotyping

July 10, 2012

RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--Quintiles announces new integrated launch planning tool, Allume, to help optimize value and minimize risk for biopharma customers

July 9, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis announces Annual Meeting

July 9, 2012

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine, the innovative ultrasound imaging company, today announced that it has been selected by the Mid-Atlantic Group Network of Shared Services (MAGNET) to provide its Participating...

July 9, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported preliminary revenue results for the three and six months ended June 30, 2012. Revenue for the...

July 9, 2012

RICHMOND, Va.--(BUSINESS WIRE)--AI BioTech, LLC today announced award of a single new government contract valued at about $ 4.3 million. The five-year contract will focus on next gen sequence and bioinformatic analysis

July 9, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that it has commenced a $80 million...

July 9, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex to release its second quarter 2012 financial results August 2, 2012. On August 3, 2012 Furiex to conduct a conference call and audio webcast to discuss financial results and product portfolio

July 9, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (Nasdaq: CDXS) today unveiled results from the pilot-scale demonstration of the company’s carbon capture technology conducted at the National Carbon Capture Center (NCCC) in Wilsonville,...

July 9, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics Submits Augment® Bone Graft PMA Amendment to FDA

July 9, 2012

MOSS BEACH, Calif.--(BUSINESS WIRE)--Study comparing clinical trials results of skin substitutes for the treatment of venous leg ulcers reports that the most expensive products may not provide the greatest clinical or cost efficacy.

July 9, 2012

WINTER PARK, Fla.--(BUSINESS WIRE)--Ascendx Spine™ (www.ascendxspine.com), which has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System...

July 9, 2012

WASHINGTON--(BUSINESS WIRE)--Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Preet Bharara, U.S. Attorney for the Southern District of New York, to investigate the short-selling activities of hedge fund manager Martin...

July 9, 2012

LONDON--(BUSINESS WIRE)--TranScrip, the leading contract organisation that supports clinical and regulatory product development, applauds landmarks in the battle for new antibiotics.

July 9, 2012

CINCINNATI--(BUSINESS WIRE)--BioRx acquires hemophilia specialty pharmacy in Minnesota

July 9, 2012

NASHVILLE, Tenn. & ALPHARETTA, Ga.--(BUSINESS WIRE)--On June 1, 2012, Nashville-based SpecialtyCare, continuing to demonstrate commitment to intraoperative neuromonitoring, acquires NeuroMatrix, an Alpharetta, GA, Company that is a recognized...

July 9, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today announced that Ashok D. Marin has joined the company as General Counsel, Chief Compliance Officer, and Corporate Secretary.

July 9, 2012

SUZHOU, China--(BUSINESS WIRE)--SIP's population of around 700,000 includes 20,000 foreigners and boasts lakes, office buildings in landscaped greenery, shopping malls and entertainment centers, well-organized traffic.

July 9, 2012

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--CRF Health, a leading global provider of eCOA solutions for the life sciences industry, announced that Mark Maietta, has been appointed as Senior VP of Global Business Development.

July 9, 2012

CASPER, Wyo.--(BUSINESS WIRE)--The Wyoming Foundation for Cancer Care, a non-profit organization dedicated to expanding cancer education and awareness announced that it has received a $150,000 grant from Susan G. Komen For the Cure

July 9, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution® Colonic Controlled-Release Stent, Cook announced today.

July 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, Heidi Rehm, PhD, has joined the company’s scientific advisory board.

July 9, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale presented data from research studies on phospho-protein analysis of the in vitro and in vivo kinase expression in the MAP kinase pathway at the EACR.

July 9, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

July 9, 2012

SALT LAKE CITY--(BUSINESS WIRE)--University of Miami Health Center purchases MicroThermX® Microwave Ablation System from BSD Medical for use at Sylvester Comprehensive Cancer Center and the University of Miami Hospital.

July 9, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

July 9, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Data and Safety Monitoring Board (DSMB), an independent group of medical experts...

July 9, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application with...

July 9, 2012

TOKYO & SANTA CLARA, Calif.--(BUSINESS WIRE)--Astellas Pharma Inc. (Tokyo: 4503) and XenoPort, Inc. (NASDAQ: XNPT) announced today that Regnite® (gabapentin enacarbil) Extended-Release Tablets will be launched in Japan on July 10, 2012....